Neylan John F.
Officer at ELTX; Chief Medical Officer at KERYX BIOPHARMACEUTICALS INC
- Sold, on record
- $246k
- Dollars the filings state
- Form 4 sales
- 31
- Latest Dec 20, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ELTXElicio Therapeutics, Inc.Officer
- KERYX BIOPHARMACEUTICALS INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- KERYX BIOPHARMACEUTICALS INC40,471 shares
- ELTX3,779 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ELTXPlan not statedMay 18 2021
Sold 363 shares at $13.91 ($5k)
Neylan John F., Officer
Sold 1% of holdings ($530k position)37,729 shares leftFiling
- 2 Form 4 sale ELTXPlan not statedJun 18 +31 days
Sold 366 shares at $13.20 ($5k)
Neylan John F., Officer
Sold 1% of holdings ($498k position)37,363 shares left1x usual sizeFiling
- 3 Form 4 sale ELTXPlan not statedJul 21 +33 days
Sold 365 shares at $10.98 ($4k)
Neylan John F., Officer
Sold 1% of holdings ($410k position)36,998 shares left1x usual sizeFiling
- 4 Form 4 sale ELTXPlan not statedAug 18 +28 days
Sold 381 shares at $9.03 ($3k)
Neylan John F., Officer
Sold 1% of holdings ($334k position)36,617 shares left1x usual sizeFiling
- 5 Form 4 sale ELTXPlan not statedSep 20 +33 days
Sold 376 shares at $10.07 ($4k)
Neylan John F., Officer
Sold 1% of holdings ($369k position)36,241 shares left1x usual sizeFiling
- 6 Form 4 sale ELTXPlan not statedOct 18 +28 days
Sold 373 shares at $8.62 ($3k)
Neylan John F., Officer
Sold 1% of holdings ($312k position)35,868 shares left1x usual sizeFiling
- 7 Form 4 sale ELTXPlan not statedNov 18 +31 days
Sold 374 shares at $4.13 ($2k)
Neylan John F., Officer
Sold 1% of holdings ($148k position)35,494 shares left1x usual sizeFiling
- 8 Form 4 sale ELTXPlan not statedDec 20 +32 days
Sold 358 shares at $2.62 ($938)
Neylan John F., Officer
Sold 1% of holdings ($93k position)35,136 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (31)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ELTX | Officer | Form 4 sale | 358 | $938 | 1.0% | Plan not stated | SEC |
| Nov 18, 2021 | ELTX | Officer | Form 4 sale | 374 | $2k | 1.0% | Plan not stated | SEC |
| Oct 18, 2021 | ELTX | Officer | Form 4 sale | 373 | $3k | 1.0% | Plan not stated | SEC |
| Sep 20, 2021 | ELTX | Officer | Form 4 sale | 376 | $4k | 1.0% | Plan not stated | SEC |
| Aug 18, 2021 | ELTX | Officer | Form 4 sale | 381 | $3k | 1.0% | Plan not stated | SEC |
| Jul 21, 2021 | ELTX | Officer | Form 4 sale | 365 | $4k | 1.0% | Plan not stated | SEC |
| Jun 18, 2021 | ELTX | Officer | Form 4 sale | 366 | $5k | 1.0% | Plan not stated | SEC |
| May 18, 2021 | ELTX | Officer | Form 4 sale | 363 | $5k | 1.0% | Plan not stated | SEC |
| Apr 19, 2021 | ELTX | Officer | Form 4 sale | 381 | $5k | 1.0% | Plan not stated | SEC |
| Mar 17, 2021 | ELTX | Officer | Form 4 sale | 442 | $8k | 1.1% | Plan not stated | SEC |
| Nov 15, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,156 | $3k | 0.8% | Plan not stated | SEC |
| Oct 29, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,253 | $4k | 0.8% | Plan not stated | SEC |
| Aug 15, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,186 | $4k | 0.8% | Plan not stated | SEC |
| Jul 30, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,282 | $5k | 0.8% | Plan not stated | SEC |
| May 15, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,158 | $7k | 0.8% | Plan not stated | SEC |
| Apr 30, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,311 | $6k | 0.8% | Plan not stated | SEC |
| Apr 23, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,111 | $5k | 0.7% | Plan not stated | SEC |
| Feb 15, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 5,652 | $27k | 4.7% | Unusual | SEC |
| Jan 29, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,541 | $7k | 1.3% | Plan not stated | SEC |
| Jan 23, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,322 | $7k | 1.1% | Plan not stated | SEC |
| Oct 30, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,405 | $8k | 1.1% | Plan not stated | SEC |
| Oct 23, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,179 | $8k | 0.9% | Plan not stated | SEC |
| Jul 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,445 | $10k | 1.1% | Plan not stated | SEC |
| Jul 24, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,214 | $9k | 0.9% | Plan not stated | SEC |
| May 1, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,441 | $9k | 1.1% | Plan not stated | SEC |
| Apr 24, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,209 | $7k | 0.9% | Plan not stated | SEC |
| Jan 30, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 6,984 | $32k | 7.7% | Unusual | SEC |
| Jan 23, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,428 | $8k | 1.6% | Plan not stated | SEC |
| Oct 24, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,211 | $6k | 1.3% | Plan not stated | SEC |
| Jul 25, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,217 | $9k | 1.3% | Plan not stated | SEC |
| Apr 25, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 4,766 | $25k | 4.8% | Plan not stated | SEC |